Primary outcomes for the comparison between bivalirudin and heparin were the occurrence of major adverse cardiovascular events ( a composite of death , myocardial infarction , or stroke ) and net adverse clinical events ( a composite of major bleeding or a major adverse cardiovascular event ) .